[The role of mevalonate pathway in osteogenic cells].
Ishimi
Yoshiko
Y
Division of Applied Food Research, National Institute of Health and Nutrition.
D000214:Acyl Coenzyme A / Q000378:metabolism; D000818:Animals; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000235:genetics / Q000502:physiology; D001862:Bone Resorption / Q000517:prevention & control; D002454:Cell Differentiation / Q000187:drug effects; D004164:Diphosphonates / Q000494:pharmacology; D050723:Fractures, Bone / Q000517:prevention & control; D019204:GTP-Binding Proteins / Q000502:physiology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D008798:Mevalonic Acid / Q000378:metabolism*; D010006:Osteoblasts / Q000166:cytology*; D010010:Osteoclasts / Q000166:cytology*; D010012:Osteogenesis / Q000187:drug effects; D010024:Osteoporosis / Q000517:prevention & control; D011106:Polyisoprenyl Phosphates; D017368:Protein Prenylation / Q000187:drug effects; D012717:Sesquiterpenes; D015398:Signal Transduction; D016212:Transforming Growth Factor beta
D000214:Acyl Coenzyme A; C525718:BMP2 protein, human; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D004164:Diphosphonates; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011106:Polyisoprenyl Phosphates; D012717:Sesquiterpenes; D016212:Transforming Growth Factor beta; C008047:3-hydroxy-3-methylglutaryl-coenzyme A; C004808:farnesyl pyrophosphate; D019204:GTP-Binding Proteins; C002963:geranylgeranyl pyrophosphate; D008798:Mevalonic Acid